Horizon Pharma plc to Participate in Two Conferences in June
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Leerink Partners Starts Horizon Pharma (HZNP) at Outperform
May 22, 2015 7:00 AM EDTLeerink Partners initiates coverage on Horizon Pharma (NASDAQ: HZNP) with a Outperform rating and a price target of $37.00.
Analyst Jason Gerberry commented, "We are initiating coverage of HZNP with an Outperform rating based on: (1) under-appreciated durability of legacy primary care brands while... More
